UL - Unilever PLC
NYSE
->
Consumer Defensive
->
Household & Personal Products
London,
United Kingdom
Type: Equity
UL price evolution
UL
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jun 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2790 | |||
| Short term investments | ||||
| Net receivables | $6202 | $8838 | $7437 | |
| Inventory | $5119 | $6035 | $5931 | |
| Total current assets | $17902 | $21675 | $19157 | |
| Long term investments | $1299 | $1187 | ||
| Property, plant & equipment | $10707 | $11276 | $10770 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $75266 | $83488 | $77821 | |
| Current liabilities | ||||
| Accounts payable | $16857 | $18492 | $18023 | |
| Deferred revenue | ||||
| Short long term debt | $7122 | $6028 | ||
| Total current liabilities | $23507 | $27266 | $25427 | |
| Long term debt | $24535 | $23993 | $23713 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $57164 | $60147 | $58800 | |
| Shareholders' equity | ||||
| Retained earnings | -$34830 | $42256 | -$33915 | |
| Other shareholder equity | -$2150 | -$78116 | -$72723 | |
| Total shareholder equity | $23341 | $22327 | ||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2862 | $2553 | $2505 | $6337.48 |
| Short term investments | ||||
| Net receivables | $5686 | $7437 | $5733 | $5311 |
| Inventory | $5119 | $5931 | $4673 | $4462 |
| Total current assets | $17902 | $19157 | $17362 | $16158 |
| Long term investments | $1187 | $1196 | $938 | |
| Property, plant & equipment | $10707 | $10770 | $10323 | $10570 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $58830.73 | |||
| Total investments | ||||
| Total assets | $75266 | $77821 | $74927 | $67662 |
| Current liabilities | ||||
| Accounts payable | $10355 | $18023 | $14827 | $8375 |
| Deferred revenue | ||||
| Short long term debt | $5815 | $7236 | $4286 | |
| Total current liabilities | $23507 | $25427 | $24723 | $20593 |
| Long term debt | $23692 | $23713 | $22830 | $22482 |
| Total noncurrent liabilities | $33597.33 | |||
| Total debt | ||||
| Total liabilities | $57164 | $58800 | $55225 | $50006 |
| Shareholders' equity | ||||
| Retained earnings | -$26831 | -$33915 | $46640 | $22550 |
| Other shareholder equity | -$2150 | -$5803 | -$76329 | -$68593 |
| Total shareholder equity | $22327 | $17069 | $15267 | |
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $31117 | $29176 | $30428 | $30450 |
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $25017 | $24453 | $25220 | $25811 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $1550 | $814 | $1385 | $925 |
| Interest expense | -$260 | -$186 | -$201 | -$180 |
| Net income | ||||
| Net income | $3701 | $2939 | $3548 | $4737 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $59604 | $61806 | $53563 | $50379 |
| Cost of revenue | $36043 | $28489 | ||
| Gross Profit | $61806 | $54564 | $21890 | |
| Operating activities | ||||
| Research & development | $912 | $794 | ||
| Selling, general & administrative | $13627 | $11793 | ||
| Total operating expenses | $49673 | $48457.51 | ||
| Operating income | $11065 | $9054 | $7763 | |
| Income from continuing operations | ||||
| EBIT | $11065 | $19682 | $18607 | |
| Income tax expense | $2199 | $2128 | $1976 | $1909 |
| Interest expense | -$387 | $785 | $501 | $642 |
| Net income | ||||
| Net income | $6487 | $8507 | $6762 | $6032 |
| Income (for common shares) | $8507 | $6762 | $6032 | |
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jun 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Net income | $4133 | $8507 | ||
| Operating activities | ||||
| Depreciation | $803 | $2002 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $3584 | $7492 | ||
| Investing activities | ||||
| Capital expenditures | -$583 | -$1414 | ||
| Investments | ||||
| Total cash flows from investing | -$392 | -$2294 | -$213 | $2524 |
| Financing activities | ||||
| Dividends paid | -$2136 | -$4363 | -$2345 | -$4454 |
| Sale and purchase of stock | -$802 | |||
| Net borrowings | ||||
| Total cash flows from financing | -$2154 | -$7193 | -$2650 | -$9146 |
| Effect of exchange rate | -$9 | -$119 | -$34 | -$7 |
| Change in cash and equivalents | $809 | -$180 | $687 | $862 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $8507 | $6178 | $5543 | |
| Operating activities | ||||
| Depreciation | $2002 | $1800 | $2004 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $7492 | $7795 | $8731 | |
| Investing activities | ||||
| Capital expenditures | -$1414 | -$1289 | -$724 | |
| Investments | ||||
| Total cash flows from investing | -$2294 | $2524 | -$3466 | -$1826 |
| Financing activities | ||||
| Dividends paid | -$4363 | -$4454 | -$4579 | -$4250 |
| Sale and purchase of stock | -$1553 | -$3140 | ||
| Net borrowings | -$561 | $1420 | $260 | |
| Total cash flows from financing | -$7193 | -$9146 | -$6752 | -$5145 |
| Effect of exchange rate | -$119 | -$7 | $297 | -$387 |
| Change in cash and equivalents | -$180 | $862 | -$2132 | $1350 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $121.17B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $14.93B |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |